Literature DB >> 9771223

Definitive repair of anovaginal fistula in Crohn's disease.

D P O'Leary1, C E Milroy, P Durdey.   

Abstract

Anovaginal fistula may be a very distressing complication of Crohn's disease. We review the definitive repair of such fistulas in ten patients. The objectives were to cure the fistula, maintain continence and avoid proctectomy. The fistula was low trans-sphincteric in five patients, high trans-sphincteric in three and suprasphincteric in two. Loop ileostomies were formed in nine patients. Overall, after 14 repair procedures 8/10 fistulas are healed. Seven remain healed at a mean of 38 months (range 10-66 months) after ileostomy closure (six) or repair without ileostomy (one). All of the patients are continent. Definitive repair is effective and worthwhile in selected patients with Crohn's anovaginal fistula.

Entities:  

Mesh:

Year:  1998        PMID: 9771223      PMCID: PMC2503092     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  17 in total

1.  Fistula-in-ano: management of Chrohn's fistula.

Authors:  J Alexander-Williams
Journal:  Dis Colon Rectum       Date:  1976-09       Impact factor: 4.585

2.  Anovaginal and rectovaginal fistulas in Crohn's disease.

Authors:  A G Radcliffe; J K Ritchie; P R Hawley; J E Lennard-Jones; J M Northover
Journal:  Dis Colon Rectum       Date:  1988-02       Impact factor: 4.585

3.  Vaginal fistulas in Crohn's disease.

Authors:  F Heyen; M C Winslet; H Andrews; J Alexander-Williams; M R Keighley
Journal:  Dis Colon Rectum       Date:  1989-05       Impact factor: 4.585

4.  Current status and influence of operation on perianal Crohn's disease.

Authors:  M R Keighley; R N Allan
Journal:  Int J Colorectal Dis       Date:  1986-04       Impact factor: 2.571

5.  Repair of rectovaginal fistulas.

Authors:  J C Greenwald; B Hoexter
Journal:  Surg Gynecol Obstet       Date:  1978-03

6.  Rectovaginal fistula in Crohn's disease.

Authors:  P A Tuxen; A F Castro
Journal:  Dis Colon Rectum       Date:  1979 Jan-Feb       Impact factor: 4.585

7.  Surgical approaches to low anovaginal fistula in Crohn's disease.

Authors:  T L Hull; V W Fazio
Journal:  Am J Surg       Date:  1997-02       Impact factor: 2.565

8.  Endorectal advancement flap for treatment of simple rectovaginal fistula.

Authors:  D A Rothenberger; C E Christenson; E G Balcos; J L Schottler; F D Nemer; S Nivatvongs; S M Goldberg
Journal:  Dis Colon Rectum       Date:  1982 May-Jun       Impact factor: 4.585

9.  The use of transanal rectal advancement flaps in the management of fistulas involving the anorectum.

Authors:  I T Jones; V W Fazio; D G Jagelman
Journal:  Dis Colon Rectum       Date:  1987-12       Impact factor: 4.585

10.  Results of operation for rectovaginal fistula in Crohn's disease.

Authors:  J G Morrison; J B Gathright; J E Ray; B T Ferrari; T C Hicks; A E Timmcke
Journal:  Dis Colon Rectum       Date:  1989-06       Impact factor: 4.585

View more
  5 in total

1.  Analysis of function and predictors of failure in women undergoing repair of Crohn's related rectovaginal fistula.

Authors:  Galal El-Gazzaz; Tracy Hull; Emilio Mignanelli; Jeffery Hammel; Brook Gurland; Massarat Zutshi
Journal:  J Gastrointest Surg       Date:  2010-03-16       Impact factor: 3.452

Review 2.  Imaging techniques and combined medical and surgical treatment of perianal Crohn's disease.

Authors:  F Botti; A Losco; C Viganò; B Oreggia; M Prati; E Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-24

3.  Perianal Crohn's Disease.

Authors:  Abhijit Basu; Steven D. Wexner
Journal:  Curr Treat Options Gastroenterol       Date:  2002-06

Review 4.  Multidisciplinary and evidence-based management of fistulizing perianal Crohn's disease.

Authors:  Ricardo Sordo-Mejia; Wolfgang B Gaertner
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

5.  Perioperative adjuvant therapy with infliximab in complicated anal Crohn's disease.

Authors:  M Kraemer; A Kirschmeier; T Marth
Journal:  Int J Colorectal Dis       Date:  2008-06-14       Impact factor: 2.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.